Kyle J. Cetrulo is the Chief Operating Officer of Mitrix Bio, a pioneering biotechnology company focused on mitochondrial transplantation to address age-related diseases. With over 20 years of experience in regenerative medicine, he has held leadership roles in several biotech ventures, including serving as CEO of Auxocell Laboratories, a company specializing in perinatal stem cell therapies. Cetrulo is also the founder of the Perinatal Stem Cell Society, an organization dedicated to advancing the clinical application of stem cells derived from perinatal tissues. His work has been instrumental in promoting the use of perinatal stem cells in medical treatments and advocating for policy changes to facilitate their clinical use. At Mitrix Bio, Cetrulo continues to drive innovation in mitochondrial science, aiming to develop therapies that can enhance healthspan and treat age-related conditions.